465 related articles for article (PubMed ID: 15857703)
1. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity.
Alttoa A; Kõiv K; Eller M; Uustare A; Rinken A; Harro J
Neuroscience; 2005; 132(4):979-90. PubMed ID: 15857703
[TBL] [Abstract][Full Text] [Related]
2. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
Alttoa A; Eller M; Herm L; Rinken A; Harro J
Brain Res; 2007 Feb; 1131(1):138-48. PubMed ID: 17156751
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Srinivasan J; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
[TBL] [Abstract][Full Text] [Related]
4. Rats with persistently high exploratory activity have both higher extracellular dopamine levels and higher proportion of D(2) (High) receptors in the striatum.
Alttoa A; Seeman P; Kõiv K; Eller M; Harro J
Synapse; 2009 May; 63(5):443-6. PubMed ID: 19184998
[TBL] [Abstract][Full Text] [Related]
5. The effect of denervation of the locus coeruleus projections with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on cocaine-induced locomotion and place preference in rats.
Kõiv K; Zobel R; Raudkivi K; Kivastik T; Harro J
Behav Brain Res; 2011 Jan; 216(1):172-9. PubMed ID: 20678524
[TBL] [Abstract][Full Text] [Related]
6. Lesioning of locus coeruleus projections by DSP-4 neurotoxin treatment: effect on amphetamine-induced hyperlocomotion and dopamine D2 receptor binding in rats.
Harro J; Meriküla A; Lepiku M; Modiri AR; Rinken A; Oreland L
Pharmacol Toxicol; 2000 May; 86(5):197-202. PubMed ID: 10862500
[TBL] [Abstract][Full Text] [Related]
7. Effect of denervation of the locus coeruleus projections by DSP-4 treatment on [3H]-raclopride binding to dopamine D(2) receptors and D(2) receptor-G protein interaction in the rat striatum.
Harro J; Terasmaa A; Eller M; Rinken A
Brain Res; 2003 Jun; 976(2):209-16. PubMed ID: 12763255
[TBL] [Abstract][Full Text] [Related]
8. Role of locus coeruleus alpha1-adrenoceptors in motor activity in rats.
Stone EA; Lin Y; Ahsan R; Quartermain D
Synapse; 2004 Dec; 54(3):164-72. PubMed ID: 15452865
[TBL] [Abstract][Full Text] [Related]
9. Rats with persistently low or high exploratory activity: behaviour in tests of anxiety and depression, and extracellular levels of dopamine.
Mällo T; Alttoa A; Kõiv K; Tõnissaar M; Eller M; Harro J
Behav Brain Res; 2007 Feb; 177(2):269-81. PubMed ID: 17141886
[TBL] [Abstract][Full Text] [Related]
10. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain.
Fritschy JM; Grzanna R
J Comp Neurol; 1992 Jul; 321(3):421-41. PubMed ID: 1506478
[TBL] [Abstract][Full Text] [Related]
11. Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression.
Zhu J; Bardo MT; Bruntz RC; Stairs DJ; Dwoskin LP
Eur J Neurosci; 2007 Aug; 26(3):717-28. PubMed ID: 17651428
[TBL] [Abstract][Full Text] [Related]
12. Functional recovery of locus coeruleus noradrenergic neurons after DSP-4 lesion: effects on dopamine levels and neuroleptic induced-parkinsonian symptoms in rats.
Srinivasan J; Schmidt WJ
J Neural Transm (Vienna); 2004 Jan; 111(1):13-26. PubMed ID: 14714212
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
[TBL] [Abstract][Full Text] [Related]
14. Denervation of the locus coeruleus projections by treatment with the selective neurotoxin DSP-4 [N (2-chloroethyl)-N-ethyl-2-bromobenzylamine] reduces dopamine release potential in the nucleus accumbens shell in conscious rats.
Häidkind R; Kivastik T; Eller M; Kolts I; Oreland L; Harro J
Neurosci Lett; 2002 Oct; 332(2):79-82. PubMed ID: 12384215
[TBL] [Abstract][Full Text] [Related]
15. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
Bailey A; Metaxas A; Yoo JH; McGee T; Kitchen I
Eur J Neurosci; 2008 Aug; 28(4):759-70. PubMed ID: 18671743
[TBL] [Abstract][Full Text] [Related]
16. DSP-4 prevents dopamine receptor priming by quinpirole.
Nowak P; Labus Ł; Kostrzewa RM; Brus R
Pharmacol Biochem Behav; 2006 May; 84(1):3-7. PubMed ID: 16675001
[TBL] [Abstract][Full Text] [Related]
17. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
Giorgi O; Piras G; Lecca D; Corda MG
Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
[TBL] [Abstract][Full Text] [Related]
18. Decrease of lymphoproliferative response by amphetamine is mediated by dopamine from the nucleus accumbens: influence on splenic met-enkephalin levels.
Assis MA; Valdomero A; García-Keller C; Sotomayor C; Cancela LM
Brain Behav Immun; 2011 May; 25(4):647-57. PubMed ID: 21237264
[TBL] [Abstract][Full Text] [Related]
19. Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion.
Fornai F; Alessandrì MG; Torracca MT; Bassi L; Scalori V; Corsini GU
Ann N Y Acad Sci; 1998 May; 844():166-77. PubMed ID: 9668674
[TBL] [Abstract][Full Text] [Related]
20. The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat.
Harro J; Tõnissaar M; Eller M
Neuropeptides; 2001 Apr; 35(2):100-9. PubMed ID: 11384205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
